MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$814,011
Operating loss
-$786,709
Total other income
(expense)
-$27,302
Total operating
expenses
$786,709
Interest expense
$22,713
Other expense
$4,000
Foreign currency gain
(loss)
-$539
General and
administrative
$650,277
Research and development
$136,432
Back
Back
Income Statement
source: myfinsight.com
REGENEREX PHARMA, INC. (RGPX)
REGENEREX PHARMA, INC. (RGPX)